SCHEMBL29320076

SCHEMBL29320076

CNCCCC(C)(C)[S+]([O-])NCc1nccc(Cl)c1F

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29591219 0.81 SSTR4 (0.31) SSTR4
SCHEMBL21355641 0.81 SSTR4 (0.31) SSTR4
SCHEMBL21545074 0.81 SSTR4 (0.31) SSTR4
SCHEMBL21455123 0.81 SSTR4 (0.31) SSTR4
SCHEMBL23656660 0.72 KLKB1 (0.32)
SCHEMBL25907039 0.72 KLKB1 (0.32)
SCHEMBL30010279 0.68
SCHEMBL21455227 0.67 F2 (0.33)
SCHEMBL23656740 0.67 F2 (0.33)
SCHEMBL23656600 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4031547-B1 PLASMA KALLIKREIN INHIBITORS AND USES THEREOF TAKEDA PHARMACEUTICALS CO (JP) 2024-07-17 EP disclosed